Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.39 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.35 |
| ▸ | PRKDC | P78527 | 1/20 | 0.33 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.32 |
| ▸ | PTPRF | P10586 | 1/20 | 0.31 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.31 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.30 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.30 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.30 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25813694 | 0.94 | PLA2G2A (0.34) | PLA2G2APLA2G4AHSP90AA1HSP90AB1ALK | |
| SCHEMBL20806485 | 0.93 | ALOX5 (0.38) | ALOX5GGPS1PRKDCPTGES2PTPRF | |
| SCHEMBL25813845 | 0.93 | ALOX5 (0.42) | ALOX5GGPS1PRKDCPTGES2PTPRF | |
| SCHEMBL25813852 | 0.93 | ALOX5 (0.43) | ALOX5GGPS1PRKDCPTGES2PTPRF | |
| SCHEMBL25813846 | 0.92 | ALOX5 (0.40) | ALOX5GGPS1PRKDCPTGES2PTPRF | |
| SCHEMBL25813780 | 0.92 | PLA2G2A (0.32) | PLA2G2APLA2G4AHSP90AA1HSP90AB1ALK | |
| SCHEMBL25813611 | 0.92 | ALOX5 (0.44) | ALOX5GGPS1PRKDCPTGES2ALK | |
| SCHEMBL25813840 | 0.92 | ALOX5 (0.44) | ALOX5GGPS1PRKDCPTGES2PLA2G2A | |
| SCHEMBL18697099 | 0.91 | ALOX5 (0.40) | ALOX5GGPS1PRKDCPTGES2PTPRF | |
| SCHEMBL25813687 | 0.91 | ALOX5 (0.42) | ALOX5GGPS1PRKDCPTGES2PLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230225196-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2023-07-13 | — | — | US | disclosed |
| US-20230225196-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230225196-A1 | MATERIALS FOR ELECTRONIC DEVICES | SELE, EPHA6, EPX | ALOX5 4246/4885GGPS1 3278/4885PRKDC 1243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.